Elutia Inc. (ELUT) vs TELA Bio, Inc. (TELA)

Elutia Inc. and TELA Bio, Inc. are both Medical Devices companies. Elutia Inc. and TELA Bio, Inc. are of similar size ($35.2M and $33.3M). TELA Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; Elutia Inc. trades at 0.6×. TELA Bio, Inc. grew revenue faster over the last twelve months: 6.09% against −18.2%. Elutia Inc. has the higher net margin (488.2% vs −51.5%) and the higher return on invested capital (0.00% vs −217.1%). Across the 17 metrics below, TELA Bio, Inc. leads on 12 and Elutia Inc. on 5.

Valuation

Metric ELUT TELA Medical Devices median
P/E 0.63 n/m 25.58
P/S 2.84 0.60 2.54
P/B 2.19 n/m 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 3.35 0.97 2.72
Earnings yield 157.69% (91.67%) (12.82%)
Free cash flow yield (133.43%) (71.78%) (8.18%)

Profitability

Metric ELUT TELA Medical Devices median
Gross margin 57.76% 68.29% 57.76%
Operating margin (214.85%) (42.56%) (15.07%)
Net margin 488.15% (51.53%) (14.45%)
Free cash flow margin (379.26%) (39.57%) (3.88%)
Return on equity (454.01%) 1,232.54% (10.35%)
Return on assets 152.89% (64.71%) (17.26%)
Return on invested capital 0.00% (217.11%) (5.27%)

Growth

Metric ELUT TELA Medical Devices median
Revenue growth (TTM) (18.15%) 6.09% 10.41%
EPS growth (last fiscal year) 146.77% 37.59% 28.17%
Revenue growth, 5-year CAGR (22.04%) 34.54% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELUT TELA Medical Devices median
Debt to equity 0.00 (3.53) 0.04
Current ratio 1.77 2.99 2.74
Net debt to EBITDA 1.51 (0.15) 0.54

Dividend

Metric ELUT TELA Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric ELUT TELA Medical Devices median
Market cap 33.25m 35.21m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack